Association of Serum Alpha-Fetoprotein with BCLC And TNM Staging Of Hepatocellular Carcinoma to Assess its Resectability
TAJ: Journal of Teachers Association · 01.06.2026 · 39 (2) · 95-100
DOI: 10.70818/taj.v39i2.0702 ↗Kurz gefasst
Fachartikel in der Zeitschrift TAJ: Journal of Teachers Association, online erschienen am 01.06.2026. Verfasst von Md Najmul Haque und 3 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is a primary malignant tumor of liver. The amount of liver damage and the stage of the tumor determine the treatment options for HCC.
Objective
The current study was aimed to assess the serum alpha-fetoprotein with BCLC and TNM staging of hepatocellular carcinoma to assess its resectability.
Methods
This was a single-center, cross-sectional study done from September 2020 to August 2021 at the department of Hepatobiliary, pancreatic, and liver transplantation surgery at BSMMU. A total of 27 HCC patients who met the inclusion criteria were enrolled in the study. Clinical, laboratory, and imaging findings were obtained using a standardized data collecting sheet with the patients' informed agreement. AFP was measured by automated chemiluminescence analyzer (LIAISON XL, DiaSorin, Italy) in the Department of Biochemistry & Molecular Biology, BSMMU. Studied patients were divided into two groups based on AFP cut off value 38.45 ng/ml. Statistical analyses between two groups were performed using SPSS version 22. Quantitative variables were expressed as mean standard deviation and examined using an unpaired t-test. The qualitative data were represented by frequencies and percentages, and the Chi-Square test and Fisher exact test (where applicable) were used to determine any association. The statistical tests were conducted with a 95% confidence interval, and P 0.05 was deemed statistically significant.
Results
Most (48.1%) of the patients were in TNM stage III, next to that 10 (37%), 1 (3.7%), and 3 (11.1%) patients were in stage I, II and IV respectively. One third (33.3%) of the patients had BCLC stage A and C and the rest were in BCLC stage B and D. In group 1, More than 60% patients were in BCLC stage A and more than 70% patients were in TNM stage I & II, and were resectable. In group 2, more than 80% of the patients were in advanced BCLC stage (stage B, C & D) and more than 80% of the patients were in TNM stage III & IV and were unresectable. The differences were statistically significant in both groups.
Conclusions
In this study, the overall resectability was 37% and frequency of resectable patients were more in lower AFP level and TNM stages and so, the serum AFP level is a good predictor of resectability of HCC.
Zitieren
APA
Haque, M. N., Yasmin, M. R., Rahman, M. M., & Alom, M. A. (2026). Association of Serum Alpha-Fetoprotein with BCLC And TNM Staging Of Hepatocellular Carcinoma to Assess its Resectability. TAJ: Journal of Teachers Association, 39(2), 95-100. https://doi.org/10.70818/taj.v39i2.0702
Vancouver
Haque MN, Yasmin MR, Rahman MM, Alom MA. Association of Serum Alpha-Fetoprotein with BCLC And TNM Staging Of Hepatocellular Carcinoma to Assess its Resectability. TAJ: Journal of Teachers Association. 2026;39(2):95-100. doi:10.70818/taj.v39i2.0702
BibTeX
@article{Haque2026,
author = {Haque, Md Najmul and Yasmin, Mst Rupali and Rahman, Md Mafiur and Alom, Md Ashraful},
title = {Association of Serum Alpha-Fetoprotein with BCLC And TNM Staging Of Hepatocellular Carcinoma to Assess its Resectability},
journal = {TAJ: Journal of Teachers Association},
year = {2026},
volume = {39},
number = {2},
pages = {95--100},
doi = {10.70818/taj.v39i2.0702}
}
EUVIMED